Core Viewpoint - The stock of Kefu Medical (301087) has shown a slight decline in price and mixed capital flow, indicating potential volatility in investor sentiment and market performance [1][2]. Group 1: Stock Performance - As of November 18, 2025, Kefu Medical's stock closed at 42.73 yuan, down 0.56% with a turnover rate of 0.56% and a trading volume of 10,900 hands, resulting in a transaction amount of 46.80 million yuan [1]. - Over the past five days, the stock has experienced a downward trend, with a notable drop of 2.73% on November 13, 2025, and a total net outflow of main funds amounting to 470.54 thousand yuan on November 18, 2025 [2]. Group 2: Capital Flow Analysis - On November 18, 2025, the main funds saw a net outflow of 470.54 thousand yuan, accounting for 10.05% of the total transaction amount, while retail investors contributed a net inflow of 309.93 thousand yuan, representing 6.62% of the total [1][2]. - The capital flow data over the last five days indicates fluctuating investor behavior, with retail investors showing resilience despite the overall negative sentiment from main funds [2]. Group 3: Financial Metrics and Industry Comparison - Kefu Medical's total market capitalization stands at 8.93 billion yuan, with a net asset value of 4.75 billion yuan and a net profit of 260 million yuan, ranking 43rd, 29th, and 24th respectively within the medical device industry [3]. - The company reported a gross margin of 53.35% and a net profit margin of 10.82%, both of which are above the industry averages, indicating strong operational efficiency [3]. - For the first three quarters of 2025, Kefu Medical's main revenue reached 2.398 billion yuan, reflecting a year-on-year increase of 6.63%, while the net profit grew by 3.3% to 260 million yuan [3]. Group 4: Analyst Ratings - In the last 90 days, nine institutions have rated Kefu Medical with a "buy" recommendation, and the average target price set by these institutions is 53.84 yuan [4].
股票行情快报：可孚医疗（301087）11月18日主力资金净卖出470.54万元